TREM2: friend or foe in glioma?

Clicks: 12
ID: 337478
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #450 of 456 articles by views in Brain research

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 456 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Triggering receptor expressed on myeloid cells 2 (TREM2) is a neuroimmune signaling hub involved in key cellular processes including microglial phagocytosis, chemotaxis, and inflammation. Dysregulation of TREM2 has been implicated in a variety of diseases, most notably in the innate immune response to neurodegenerative disorders and cancer. The TREM2 pathway plays a significant role in governing microglia phenotypic transitions in Alzheimer's disease, as well as in regulating tumor-associated macrophages' ability to modulate cytotoxic activity. However, TREM2's role can be dependent on experimental parameters and disease contexts. Due to its intricate involvement in related disorders and the myeloid-dominated microenvironment in brain tumors, TREM2 has emerged as a vital player to better understand neuroimmune contributions to central nervous system malignancies. This review critically evaluates TREM2's controversial function in gliomas, analyzes experimental and biological variables that may underlie divergent findings, and outlines important considerations for future investigations.
Reference Key
openalex_W7224016415 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mekenzie Peshoff, Dolores Hambardzumyan, Long‐Jun Wu
Are you one of these authors? Claim your profile
Journal Brain research
Year 2026
DOI
10.1093/brain/awag369
URL
https://doi.org/10.1093/brain/awag369
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.